Home › Drug Codes › Q Codes › Q2053 · TECARTUS
Updated July 1st, 2026

TECARTUS Q Code: Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for Q2053, effective October 1, 2026: $532,352.741 per HCPCS billing unit, up 4.4% from $510,103.919. From CMS's final file.

?
Medicare Payment Limit ?
$510,103.919
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$510,103.919
/ HCPCS billing unit · APC 9391
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
4
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
HCPCS Added Date April 1, 2021
Manufacturer Gilead Sciences, Inc
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Form Suspension

About TECARTUS

Tecartus is a medication aligned to the HCPCS Q Code: Q2053 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Gilead Sciences, Inc.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. Showing 2 of 4 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
71287-0219-01 Tecartus Gilead Sciences, Inc. 1 Tecartus Intravenous S uspension 200000… Login for More
71287-0220-01 Tecartus Gilead Sciences, Inc. 1 Tecartus Intravenous S uspension 100000… Login for More
•••••-••••-•• Log in to view TECARTUS
TECARTUS
Login to view 2 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

TECARTUS Pricing & Reimbursement

Q2053 Private Payer Reimbursement
$525,680.52 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

TECARTUS CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Tecartus (Q2053) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q2053. Wastage billing guide →

TECARTUS Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Mantle Cell Lymphoma Acute Lymphoblastic Leukemia

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Tecartus billing and coding guide?
Billing and coding information for TECARTUS can be found through Kite Pharma. Visit Here →
Are there any available Tecartus patient assistance programs?
TECARTUS patient assistance information can be found through Kite Pharma. Visit Here →
Where can I find Tecartus prescribing information?
TECARTUS prescribing information can be found at the link below: Visit Here →
Where can I find Tecartus side effect information?
Information regarding TECARTUS's side effects can be found at MedlinePlus Visit Here →
Does billing TECARTUS require JZ/JW wastage modifiers?
CMS does not include TECARTUS (Q2053) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q2053. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to TECARTUS.

C9142AlymsysInjection, bevacizumab-maly, biosimilar, (alymsys), 10 mgAmneal BiosciencesAdded October 1, 2022C9146ELAHEREInjection, mirvetuximab soravtansine-gynx, 1 mgImmunogenAdded April 1, 2023C9147IMJUDOInjection, tremelimumab-actl, 1 mgAstrazenecaAdded April 1, 2023C9148TECVAYLIInjection, teclistamab-cqyv, 0.5 mgJanssenAdded April 1, 2023C9155EPKINLYInjection, epcoritamab-bysp, 0.16 mgGenmabAdded October 1, 2023C9163TALVEYInjection, talquetamab-tgvs, 0.25 mgJanssenAdded January 1, 2024C9165ELREXFIOInjection, elranatamab-bcmm, 1 mgPfizerAdded January 1, 2024C9169ANKTIVAInjection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgramAltor BioScience, LLCAdded October 1, 2024C9170IMDELLTRAInjection, tarlatamab-dlle, 1 mgAmgenAdded October 1, 2024C9173NYPOZIInjection, filgrastim-txid (nypozi), biosimilar, 1 microgramTanvex Biopharma USAAdded January 1, 2025